Biao Xu

525 total citations
17 papers, 445 citations indexed

About

Biao Xu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Clinical Biochemistry. According to data from OpenAlex, Biao Xu has authored 17 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Clinical Biochemistry. Recurrent topics in Biao Xu's work include Advanced Glycation End Products research (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Adipose Tissue and Metabolism (2 papers). Biao Xu is often cited by papers focused on Advanced Glycation End Products research (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Adipose Tissue and Metabolism (2 papers). Biao Xu collaborates with scholars based in China and United States. Biao Xu's co-authors include Jun Xie, Han Wu, Guannan Li, Ran Li, Jianzhou Chen, Qinhua Chen, Zhonghai Wei, Lina Kang, Wencheng Di and Yang Yang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Cell Death and Differentiation and Journal of Cellular Physiology.

In The Last Decade

Biao Xu

17 papers receiving 440 citations

Peers

Biao Xu

CCM

PHYSI

EDM

Yongzheng Guo China

Yun Ti China

Wenjuan Liu China

Motoki Uchihashi Japan

Santie Li China

Songping Yu China

Weijin Fang China

Kuniyoshi Fukai Japan

Shujian Wei China

Satoshi Kaimoto Japan

Yongzheng Guo China

Biao Xu

273 ×1.4

138 ×1.3

CCM

156 ×2.1

PHYSI

26 ×0.5

83 ×1.7

EDM

Citations per year, relative to Biao Xu Biao Xu (= 1×) peers Yongzheng Guo

Countries citing papers authored by Biao Xu

Since Specialization

Citations

This map shows the geographic impact of Biao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biao Xu more than expected).

Fields of papers citing papers by Biao Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Biao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biao Xu. The network helps show where Biao Xu may publish in the future.

Co-authorship network of co-authors of Biao Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Biao Xu. A scholar is included among the top collaborators of Biao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Biao Xu. Biao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Gong, Rong, Shilong Jiang, Yidi Guan, et al.. (2025). GPX4-AUTAC induces ferroptosis in breast cancer by promoting the selective autophagic degradation of GPX4 mediated by TRAF6-p62. Cell Death and Differentiation. 32(11). 2022–2037. 7 indexed citations

Di, Wencheng, Zhe Zhang, Ning Li, et al.. (2023). Activation of ITLN‐1 attenuates oxidative stress injury via activating SIRT1/PGC1‐α signaling in neuroblastoma cells. Journal of Cellular Physiology. 239(1). 67–78. 4 indexed citations

Chang, Lei, Haitao Lu, Yihai Liu, et al.. (2022). Percutaneous intravenous catheter forceps biopsy in right atrial mass: two case reports and literature review. BMC Cardiovascular Disorders. 22(1). 63–63. 6 indexed citations

Chen, Zheng, Ran Li, Zhonghai Wei, et al.. (2021). High‐mobility group box‐1 promotes vascular calcification in diabetic mice via endoplasmic reticulum stress. Journal of Cellular and Molecular Medicine. 25(8). 3724–3734. 10 indexed citations

Wu, Han, Zheng Chen, Jianzhou Chen, Jun Xie, & Biao Xu. (2018). Resveratrol Improves Tube Formation in AGE‐Induced Late Endothelial Progenitor Cells by Suppressing Syndecan‐4 Shedding. Oxidative Medicine and Cellular Longevity. 2018(1). 9045976–9045976. 14 indexed citations

Xia, Yangyang, Min Zhao, Jing Liu, et al.. (2018). Effectiveness and Safety of Peritoneal Dialysis Treatment in Patients with Refractory Congestive Heart Failure due to Chronic Cardiorenal Syndrome. BioMed Research International. 2018. 1–9. 14 indexed citations

Di, Wencheng, Jianjun Lv, Shuai Jiang, et al.. (2018). PGC-1: The Energetic Regulator in Cardiac Metabolism. Current Issues in Molecular Biology. 28. 29–46. 110 indexed citations

Cheng, Yongxia, Dawei Zhang, Ying Wang, et al.. (2017). Liver X receptor α is targeted by microRNA-1 to inhibit cardiomyocyte apoptosis through a ROS-mediated mitochondrial pathway. Biochemistry and Cell Biology. 96(1). 11–18. 11 indexed citations

Wu, Han, Jun Xie, Ran Li, et al.. (2016). Reduced HMGB 1‐Mediated Pathway and Oxidative Stress in Resveratrol‐Treated Diabetic Mice: A Possible Mechanism of Cardioprotection of Resveratrol in Diabetes Mellitus. Oxidative Medicine and Cellular Longevity. 2016(1). 9836860–9836860. 35 indexed citations

10.

Wu, Han, Zheng Chen, Jun Xie, et al.. (2016). High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications. Mediators of Inflammation. 2016. 1–11. 44 indexed citations

11.

Wu, Han, Guannan Li, Jun Xie, et al.. (2016). Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice. BMC Cardiovascular Disorders. 16(1). 5–5. 108 indexed citations

12.

Xie, Jun, Qinhua Chen, Jiayin Sun, et al.. (2016). Syndecan-4 Signaling Is Required for Exercise-Induced Cardiac Hypertrophy. Molecular Medicine. 22(1). 192–201. 10 indexed citations

13.

Li, Ran, Han Wu, Jun Xie, et al.. (2016). Syndecan-4 regulates the bFGF-induced chemotactic migration of endothelial cells. Journal of Molecular Histology. 47(5). 503–509. 9 indexed citations

14.

Li, Ran, Jun Xie, Han Wu, et al.. (2016). Syndecan-4 shedding impairs macrovascular angiogenesis in diabetes mellitus. Biochemical and Biophysical Research Communications. 474(1). 15–21. 18 indexed citations

15.

Xu, Na, Shan Guan, Zhong Chen, et al.. (2014). The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb–mTORC1 signalling and leads to chronic heart failure. The Journal of Pathology. 235(5). 672–685. 43 indexed citations

16.

Ma, Jiangwei, Zengyong Qiao, & Biao Xu. (2013). Expression of sPLA2-V, estrogen and its target protein in myocardium tissue. International Journal of Biological Macromolecules. 58. 176–178. 1 indexed citations

17.

Xu, Biao, et al.. (2004). Effects of advanced glycation end products on activity and expression of eNOS in human umbilical vein endothelial cells. 32(5). 283–287. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact